

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.64879184 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64879184 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.32060649 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32060649 |
| 5 | * aromatic amino acid family catabolic process (GO:0009074) | 6.84815187 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.28162284 |
| 7 | * indole-containing compound catabolic process (GO:0042436) | 6.11004926 |
| 8 | * indolalkylamine catabolic process (GO:0046218) | 6.11004926 |
| 9 | * tryptophan catabolic process (GO:0006569) | 6.11004926 |
| 10 | bile acid biosynthetic process (GO:0006699) | 6.08446446 |
| 11 | * kynurenine metabolic process (GO:0070189) | 5.88491103 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.83783881 |
| 13 | * tryptophan metabolic process (GO:0006568) | 5.72440112 |
| 14 | urea metabolic process (GO:0019627) | 5.69045297 |
| 15 | urea cycle (GO:0000050) | 5.69045297 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65072857 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.58824707 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52589608 |
| 19 | behavioral response to nicotine (GO:0035095) | 5.43399003 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.43062001 |
| 21 | protein carboxylation (GO:0018214) | 5.42716029 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42716029 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.42636945 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.41224896 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.39339274 |
| 26 | cysteine metabolic process (GO:0006534) | 5.33575125 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.23426623 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.21167800 |
| 29 | bile acid metabolic process (GO:0008206) | 5.19908889 |
| 30 | regulation of complement activation (GO:0030449) | 5.05375146 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92843932 |
| 32 | * aromatic amino acid family metabolic process (GO:0009072) | 4.90279295 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.82819113 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.79499072 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.78439656 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.78287434 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.72756091 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.69106263 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.69106263 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69106263 |
| 41 | lysine catabolic process (GO:0006554) | 4.68170844 |
| 42 | lysine metabolic process (GO:0006553) | 4.68170844 |
| 43 | * alpha-amino acid catabolic process (GO:1901606) | 4.68102790 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.65646339 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.65646339 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.62618838 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.61647584 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.56279866 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.56279866 |
| 50 | DNA deamination (GO:0045006) | 4.56011260 |
| 51 | phospholipid efflux (GO:0033700) | 4.52881350 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.51750685 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.50160575 |
| 54 | glycine metabolic process (GO:0006544) | 4.49481076 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.47604112 |
| 56 | cellular glucuronidation (GO:0052695) | 4.34513375 |
| 57 | * cellular amino acid catabolic process (GO:0009063) | 4.31019308 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.29482412 |
| 59 | fucose catabolic process (GO:0019317) | 4.28086357 |
| 60 | L-fucose metabolic process (GO:0042354) | 4.28086357 |
| 61 | L-fucose catabolic process (GO:0042355) | 4.28086357 |
| 62 | glutamate metabolic process (GO:0006536) | 4.27581374 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 4.23121194 |
| 64 | * indolalkylamine metabolic process (GO:0006586) | 4.21964992 |
| 65 | ethanol oxidation (GO:0006069) | 4.21588763 |
| 66 | cholesterol efflux (GO:0033344) | 4.14987468 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 4.13261823 |
| 68 | platelet dense granule organization (GO:0060155) | 4.12969183 |
| 69 | * cellular biogenic amine catabolic process (GO:0042402) | 4.12663627 |
| 70 | * amine catabolic process (GO:0009310) | 4.12663627 |
| 71 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.11487649 |
| 72 | arginine metabolic process (GO:0006525) | 4.09205499 |
| 73 | drug catabolic process (GO:0042737) | 4.06176279 |
| 74 | fibrinolysis (GO:0042730) | 4.04553304 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 4.03611180 |
| 76 | aldehyde catabolic process (GO:0046185) | 4.01367255 |
| 77 | * benzene-containing compound metabolic process (GO:0042537) | 3.97295738 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95206877 |
| 79 | ketone body metabolic process (GO:1902224) | 3.90599822 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.89214042 |
| 81 | cofactor catabolic process (GO:0051187) | 3.87280085 |
| 82 | complement activation, classical pathway (GO:0006958) | 3.86605297 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.85850374 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.85850374 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 3.85434201 |
| 86 | cytolysis (GO:0019835) | 3.85145379 |
| 87 | complement activation (GO:0006956) | 3.79665047 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78423924 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78004841 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78004841 |
| 91 | protein activation cascade (GO:0072376) | 3.75752296 |
| 92 | * organic acid catabolic process (GO:0016054) | 3.75198048 |
| 93 | * carboxylic acid catabolic process (GO:0046395) | 3.75198048 |
| 94 | NAD biosynthetic process (GO:0009435) | 3.74381466 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.73024462 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.72374309 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71116129 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.71013788 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.70994320 |
| 100 | phospholipid homeostasis (GO:0055091) | 3.68644657 |
| 101 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.67651709 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.67651709 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 3.67188221 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.65283352 |
| 105 | sterol homeostasis (GO:0055092) | 3.65234592 |
| 106 | exogenous drug catabolic process (GO:0042738) | 3.59144473 |
| 107 | response to pheromone (GO:0019236) | 3.37815574 |
| 108 | positive regulation of defense response to virus by host (GO:0002230) | 3.21794621 |
| 109 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.05660759 |
| 110 | detection of light stimulus involved in visual perception (GO:0050908) | 3.05354644 |
| 111 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.05354644 |
| 112 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.04233721 |
| 113 | respiratory chain complex IV assembly (GO:0008535) | 3.01531537 |
| 114 | negative regulation of mast cell activation (GO:0033004) | 3.00983379 |
| 115 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.99555972 |
| 116 | protein localization to cilium (GO:0061512) | 2.94202659 |
| 117 | sulfation (GO:0051923) | 2.92794478 |
| 118 | cytidine metabolic process (GO:0046087) | 2.92463342 |
| 119 | cytidine catabolic process (GO:0006216) | 2.92463342 |
| 120 | cytidine deamination (GO:0009972) | 2.92463342 |
| 121 | axoneme assembly (GO:0035082) | 2.91860190 |
| 122 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.91597211 |
| 123 | mannosylation (GO:0097502) | 2.90403354 |
| 124 | neural tube formation (GO:0001841) | 2.88408979 |
| 125 | multicellular organism reproduction (GO:0032504) | 2.84790807 |
| 126 | S-adenosylmethionine metabolic process (GO:0046500) | 2.84763154 |
| 127 | parturition (GO:0007567) | 2.84096103 |
| 128 | synaptic transmission, cholinergic (GO:0007271) | 2.83921669 |
| 129 | cellular response to ATP (GO:0071318) | 2.83610307 |
| 130 | negative regulation of telomere maintenance (GO:0032205) | 2.81544460 |
| 131 | piRNA metabolic process (GO:0034587) | 2.79603323 |
| 132 | protein complex biogenesis (GO:0070271) | 2.79297564 |
| 133 | gamma-aminobutyric acid transport (GO:0015812) | 2.78883725 |
| 134 | protein-cofactor linkage (GO:0018065) | 2.78505403 |
| 135 | * indole-containing compound metabolic process (GO:0042430) | 2.74693645 |
| 136 | epithelial cilium movement (GO:0003351) | 2.74057443 |
| 137 | neuronal action potential (GO:0019228) | 2.73269153 |
| 138 | positive regulation of fatty acid transport (GO:2000193) | 2.70997011 |
| 139 | ubiquinone biosynthetic process (GO:0006744) | 2.70900343 |
| 140 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.70094666 |
| 141 | cytochrome complex assembly (GO:0017004) | 2.67770248 |
| 142 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.67390500 |
| 143 | oxidative demethylation (GO:0070989) | 2.65593966 |
| 144 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.63301866 |
| 145 | adaptation of signaling pathway (GO:0023058) | 2.59155360 |
| 146 | protein polyglutamylation (GO:0018095) | 2.58587672 |
| 147 | positive regulation of prostaglandin secretion (GO:0032308) | 2.56978917 |
| 148 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.55156396 |
| 149 | glycerophospholipid catabolic process (GO:0046475) | 2.54151864 |
| 150 | sulfate transmembrane transport (GO:1902358) | 2.53998046 |
| 151 | kidney morphogenesis (GO:0060993) | 2.53257018 |
| 152 | ubiquinone metabolic process (GO:0006743) | 2.52750836 |
| 153 | dopamine transport (GO:0015872) | 2.51354986 |
| 154 | cornea development in camera-type eye (GO:0061303) | 2.51347412 |
| 155 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.49142854 |
| 156 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.49142854 |
| 157 | NADH dehydrogenase complex assembly (GO:0010257) | 2.49142854 |
| 158 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.47480944 |
| 159 | cilium morphogenesis (GO:0060271) | 2.47159934 |
| 160 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.47031536 |
| 161 | cAMP catabolic process (GO:0006198) | 2.45815025 |
| 162 | estrogen biosynthetic process (GO:0006703) | 2.43739526 |
| 163 | reflex (GO:0060004) | 2.43099557 |
| 164 | behavioral response to ethanol (GO:0048149) | 2.42556598 |
| 165 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.42195013 |
| 166 | rRNA catabolic process (GO:0016075) | 2.40929804 |
| 167 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.40855304 |
| 168 | regulation of cilium movement (GO:0003352) | 2.38053207 |
| 169 | primary amino compound metabolic process (GO:1901160) | 2.37675301 |
| 170 | signal peptide processing (GO:0006465) | 2.37555179 |
| 171 | adenosine metabolic process (GO:0046085) | 2.35572718 |
| 172 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.35026015 |
| 173 | positive regulation of icosanoid secretion (GO:0032305) | 2.33465097 |
| 174 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.31574910 |
| 175 | regulation of action potential (GO:0098900) | 2.30987268 |
| 176 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.30809160 |
| 177 | auditory receptor cell stereocilium organization (GO:0060088) | 2.29799245 |
| 178 | regulation of glucokinase activity (GO:0033131) | 2.29161411 |
| 179 | regulation of hexokinase activity (GO:1903299) | 2.29161411 |
| 180 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.29075044 |
| 181 | photoreceptor cell maintenance (GO:0045494) | 2.28779096 |
| 182 | photoreceptor cell development (GO:0042461) | 2.27740583 |
| 183 | DNA methylation involved in gamete generation (GO:0043046) | 2.26965425 |
| 184 | nephron tubule morphogenesis (GO:0072078) | 2.26089138 |
| 185 | nephron epithelium morphogenesis (GO:0072088) | 2.26089138 |
| 186 | regulation of memory T cell differentiation (GO:0043380) | 2.25810123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41673400 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19781661 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13435996 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48383563 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31908145 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.04760867 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.73837875 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07944528 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01227527 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.73514700 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 3.48295847 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.66488727 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52648791 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49260366 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.31531830 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.27517962 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.23239965 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.14789624 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10406579 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05293594 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02720193 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9600008 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95130316 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93180865 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92769569 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.87208286 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87205188 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85211899 |
| 29 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.79621732 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76844090 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.76745295 |
| 32 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.76561733 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58961625 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57496259 |
| 35 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.54071127 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53584158 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48964551 |
| 38 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.48940411 |
| 39 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.48940411 |
| 40 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44847815 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44847815 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44235614 |
| 43 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.42274623 |
| 44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.42274623 |
| 45 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41229571 |
| 46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40491897 |
| 47 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39358104 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37555042 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36811123 |
| 50 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36736375 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35574397 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35076971 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34881067 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34804310 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34710323 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32262325 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32115382 |
| 58 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30490122 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30196498 |
| 60 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29944305 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29658928 |
| 62 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.29208552 |
| 63 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.27957718 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27196171 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26325631 |
| 66 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25703428 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25665263 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25579939 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25497557 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25451871 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25187603 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25118045 |
| 73 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24862331 |
| 74 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.24066086 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23761545 |
| 76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23140376 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22284927 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19212757 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19212757 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18917819 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18399358 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18367318 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16313209 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15357210 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15013924 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14840156 |
| 87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13875538 |
| 88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13665232 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12948902 |
| 90 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.11638594 |
| 91 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11233869 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11129763 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10388158 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09804642 |
| 95 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09675122 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.09609907 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09540313 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08457001 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07669958 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07172303 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04325940 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03923901 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03703849 |
| 104 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03557220 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03197315 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01918122 |
| 107 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01036870 |
| 108 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00111607 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99899362 |
| 110 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98596959 |
| 111 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98366916 |
| 112 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98061443 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87162013 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85554834 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85406847 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85362071 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82348061 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81721725 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79805438 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78016416 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76323823 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72862508 |
| 123 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72547758 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72221643 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71534768 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70896397 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66616803 |
| 128 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65517772 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65375313 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65022116 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64628447 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64447704 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64349372 |
| 134 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64294024 |
| 135 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62527047 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61890642 |
| 137 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61890642 |
| 138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60826893 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.60335878 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59396587 |
| 141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.56695856 |
| 142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56008032 |
| 143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54986513 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54770499 |
| 145 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54101525 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53727501 |
| 147 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53400534 |
| 148 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51858421 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51236502 |
| 150 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50834658 |
| 151 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.50358179 |
| 152 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49816977 |
| 153 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49733424 |
| 154 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49482046 |
| 155 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.48364572 |
| 156 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.47976124 |
| 157 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47338021 |
| 158 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47159136 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46834961 |
| 160 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43952866 |
| 161 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43746615 |
| 162 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43728860 |
| 163 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43316363 |
| 164 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43215798 |
| 165 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42112322 |
| 166 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41853680 |
| 167 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41457725 |
| 168 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41112851 |
| 169 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.40979300 |
| 170 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40521222 |
| 171 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39995035 |
| 172 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.39888215 |
| 173 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39503335 |
| 174 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38366319 |
| 175 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.36814780 |
| 176 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36174636 |
| 177 | GATA2_19941826_ChIP-Seq_K562_Human | 0.35570798 |
| 178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.35128327 |
| 179 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35071691 |
| 180 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35048498 |
| 181 | GATA1_19941826_ChIP-Seq_K562_Human | 0.35030091 |
| 182 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34888959 |
| 183 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34702429 |
| 184 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.34690867 |
| 185 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.34244332 |
| 186 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.33822733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37598459 |
| 2 | MP0005360_urolithiasis | 7.63853540 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.51737416 |
| 4 | MP0005365_abnormal_bile_salt | 6.21062218 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14577225 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.33595044 |
| 7 | MP0003252_abnormal_bile_duct | 3.92599494 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58986906 |
| 9 | MP0009840_abnormal_foam_cell | 3.20451742 |
| 10 | MP0005083_abnormal_biliary_tract | 3.10912264 |
| 11 | MP0003195_calcinosis | 2.83643603 |
| 12 | MP0005332_abnormal_amino_acid | 2.76330704 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.64424669 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.57579789 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.39385743 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.33962743 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.24396430 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.16305971 |
| 19 | MP0000609_abnormal_liver_physiology | 2.15426936 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.10445567 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.09700662 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.09191723 |
| 23 | MP0002102_abnormal_ear_morphology | 2.01226507 |
| 24 | MP0003868_abnormal_feces_composition | 1.93460317 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.92713297 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.91735286 |
| 27 | MP0003787_abnormal_imprinting | 1.88894505 |
| 28 | MP0005671_abnormal_response_to | 1.88368115 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.85765343 |
| 30 | MP0006072_abnormal_retinal_apoptosis | 1.84331985 |
| 31 | MP0004142_abnormal_muscle_tone | 1.81704694 |
| 32 | MP0009745_abnormal_behavioral_response | 1.77458349 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.76348900 |
| 34 | MP0003646_muscle_fatigue | 1.75724108 |
| 35 | MP0009697_abnormal_copulation | 1.74591447 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.74228179 |
| 37 | MP0004043_abnormal_pH_regulation | 1.73015583 |
| 38 | MP0001764_abnormal_homeostasis | 1.69217965 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.69131791 |
| 40 | MP0003136_yellow_coat_color | 1.69059377 |
| 41 | MP0004885_abnormal_endolymph | 1.67565679 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.65485732 |
| 43 | MP0003880_abnormal_central_pattern | 1.65268867 |
| 44 | MP0009046_muscle_twitch | 1.64535522 |
| 45 | MP0002736_abnormal_nociception_after | 1.64175583 |
| 46 | MP0005253_abnormal_eye_physiology | 1.64089913 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.56345095 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55705103 |
| 49 | MP0002163_abnormal_gland_morphology | 1.52808804 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.49217894 |
| 51 | MP0000427_abnormal_hair_cycle | 1.45760842 |
| 52 | MP0002272_abnormal_nervous_system | 1.45317475 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.44690863 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.43525355 |
| 55 | MP0005379_endocrine/exocrine_gland_phen | 1.41303905 |
| 56 | MP0003011_delayed_dark_adaptation | 1.38427401 |
| 57 | MP0005451_abnormal_body_composition | 1.37304252 |
| 58 | MP0004147_increased_porphyrin_level | 1.34121972 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.33522456 |
| 60 | MP0005410_abnormal_fertilization | 1.28660620 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.27384320 |
| 62 | MP0005389_reproductive_system_phenotype | 1.26244840 |
| 63 | MP0003186_abnormal_redox_activity | 1.26158200 |
| 64 | MP0009785_altered_susceptibility_to | 1.23765701 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.22714066 |
| 66 | MP0005647_abnormal_sex_gland | 1.21925118 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.20551785 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.20474279 |
| 69 | MP0001919_abnormal_reproductive_system | 1.19840439 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.19362259 |
| 71 | MP0000598_abnormal_liver_morphology | 1.15881779 |
| 72 | MP0002693_abnormal_pancreas_physiology | 1.14960716 |
| 73 | MP0002938_white_spotting | 1.14516646 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 1.11948695 |
| 75 | MP0001970_abnormal_pain_threshold | 1.11268567 |
| 76 | MP0002064_seizures | 1.10767993 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 1.10445778 |
| 78 | MP0002572_abnormal_emotion/affect_behav | 1.08560502 |
| 79 | MP0003878_abnormal_ear_physiology | 1.08478906 |
| 80 | MP0005377_hearing/vestibular/ear_phenot | 1.08478906 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.08452765 |
| 82 | MP0004133_heterotaxia | 1.08046972 |
| 83 | MP0005387_immune_system_phenotype | 1.07764358 |
| 84 | MP0001790_abnormal_immune_system | 1.07764358 |
| 85 | MP0009764_decreased_sensitivity_to | 1.07688609 |
| 86 | MP0001486_abnormal_startle_reflex | 1.07189100 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.06759087 |
| 88 | MP0004742_abnormal_vestibular_system | 1.06425677 |
| 89 | MP0002557_abnormal_social/conspecific_i | 1.05892386 |
| 90 | MP0002254_reproductive_system_inflammat | 1.05071098 |
| 91 | MP0001905_abnormal_dopamine_level | 1.04880124 |
| 92 | MP0000685_abnormal_immune_system | 1.02268037 |
| 93 | MP0000604_amyloidosis | 1.00358379 |
| 94 | MP0009763_increased_sensitivity_to | 0.99613447 |
| 95 | MP0001800_abnormal_humoral_immune | 0.99488026 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.99180574 |
| 97 | MP0002160_abnormal_reproductive_system | 0.98454780 |
| 98 | MP0001984_abnormal_olfaction | 0.98413456 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.96644583 |
| 100 | MP0002735_abnormal_chemical_nociception | 0.92134070 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.90389004 |
| 102 | MP0004924_abnormal_behavior | 0.90389004 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.89212942 |
| 104 | MP0008469_abnormal_protein_level | 0.88926166 |
| 105 | MP0002095_abnormal_skin_pigmentation | 0.87782611 |
| 106 | MP0002067_abnormal_sensory_capabilities | 0.87240380 |
| 107 | MP0005195_abnormal_posterior_eye | 0.86569294 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.86062288 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.83134071 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.83037872 |
| 111 | MP0008995_early_reproductive_senescence | 0.82382600 |
| 112 | MP0002723_abnormal_immune_serum | 0.81995353 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.80813660 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.80185071 |
| 115 | MP0005408_hypopigmentation | 0.79801185 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.79482815 |
| 117 | MP0001873_stomach_inflammation | 0.79025962 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.76985534 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.76513204 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.75429418 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.74987232 |
| 122 | MP0005670_abnormal_white_adipose | 0.74426400 |
| 123 | MP0002063_abnormal_learning/memory/cond | 0.74263490 |
| 124 | MP0005075_abnormal_melanosome_morpholog | 0.71121853 |
| 125 | MP0002971_abnormal_brown_adipose | 0.68832924 |
| 126 | MP0005334_abnormal_fat_pad | 0.68122997 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.68088027 |
| 128 | MP0005535_abnormal_body_temperature | 0.66970528 |
| 129 | MP0005266_abnormal_metabolism | 0.66571133 |
| 130 | MP0003690_abnormal_glial_cell | 0.66552148 |
| 131 | MP0001661_extended_life_span | 0.64056451 |
| 132 | MP0009053_abnormal_anal_canal | 0.62949705 |
| 133 | MP0000639_abnormal_adrenal_gland | 0.61967133 |
| 134 | MP0004130_abnormal_muscle_cell | 0.60160737 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.58111913 |
| 136 | MP0003329_amyloid_beta_deposits | 0.54992685 |
| 137 | MP0001756_abnormal_urination | 0.54300228 |
| 138 | MP0005448_abnormal_energy_balance | 0.53666133 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.52203830 |
| 140 | MP0002822_catalepsy | 0.50916939 |
| 141 | MP0008874_decreased_physiological_sensi | 0.49748559 |
| 142 | MP0005248_abnormal_Harderian_gland | 0.49119729 |
| 143 | MP0003718_maternal_effect | 0.48475680 |
| 144 | MP0005395_other_phenotype | 0.48227151 |
| 145 | MP0003638_abnormal_response/metabolism_ | 0.46543994 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.46522449 |
| 147 | MP0004381_abnormal_hair_follicle | 0.46410883 |
| 148 | MP0002928_abnormal_bile_duct | 0.44947259 |
| 149 | MP0003075_altered_response_to | 0.42968822 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.42863224 |
| 151 | MP0008873_increased_physiological_sensi | 0.41801574 |
| 152 | MP0003724_increased_susceptibility_to | 0.41143101 |
| 153 | MP0003436_decreased_susceptibility_to | 0.40829372 |
| 154 | MP0003953_abnormal_hormone_level | 0.40792332 |
| 155 | MP0005166_decreased_susceptibility_to | 0.40101229 |
| 156 | MP0008872_abnormal_physiological_respon | 0.39044602 |
| 157 | MP0006082_CNS_inflammation | 0.38049986 |
| 158 | MP0002837_dystrophic_cardiac_calcinosis | 0.34368806 |
| 159 | MP0009115_abnormal_fat_cell | 0.34159737 |
| 160 | MP0000579_abnormal_nail_morphology | 0.33657006 |
| 161 | MP0009672_abnormal_birth_weight | 0.33390461 |
| 162 | MP0002796_impaired_skin_barrier | 0.33142237 |
| 163 | MP0004883_abnormal_blood_vessel | 0.30518847 |
| 164 | MP0002168_other_aberrant_phenotype | 0.30499958 |
| 165 | MP0000249_abnormal_blood_vessel | 0.30499679 |
| 166 | MP0002132_abnormal_respiratory_system | 0.29798961 |
| 167 | MP0002970_abnormal_white_adipose | 0.29775264 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.28990879 |
| 169 | MP0005666_abnormal_adipose_tissue | 0.28690816 |
| 170 | MP0001881_abnormal_mammary_gland | 0.27645742 |
| 171 | MP0001243_abnormal_dermal_layer | 0.27266668 |
| 172 | MP0001853_heart_inflammation | 0.26566195 |
| 173 | MP0001845_abnormal_inflammatory_respons | 0.26431297 |
| 174 | MP0004264_abnormal_extraembryonic_tissu | 0.25043832 |
| 175 | MP0005167_abnormal_blood-brain_barrier | 0.23598024 |
| 176 | MP0005164_abnormal_response_to | 0.23396144 |
| 177 | MP0009384_cardiac_valve_regurgitation | 0.22687735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.45132507 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.44567199 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.38552439 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71485591 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.63736206 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.42792968 |
| 7 | Xanthomatosis (HP:0000991) | 6.15815352 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.55124349 |
| 9 | Complement deficiency (HP:0004431) | 5.48231912 |
| 10 | Joint hemorrhage (HP:0005261) | 4.84355262 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.74686614 |
| 12 | Hyperammonemia (HP:0001987) | 4.61913447 |
| 13 | Hyperglycinemia (HP:0002154) | 4.59513236 |
| 14 | Epidermoid cyst (HP:0200040) | 4.39947468 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35368890 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32087688 |
| 17 | Pancreatic cysts (HP:0001737) | 4.26345450 |
| 18 | Ketosis (HP:0001946) | 4.26071517 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25980737 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.23863495 |
| 21 | Fat malabsorption (HP:0002630) | 4.18182997 |
| 22 | Congenital stationary night blindness (HP:0007642) | 4.17897938 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13263786 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.10521499 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08473346 |
| 26 | Hyperglycinuria (HP:0003108) | 4.01865938 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.00278931 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 4.00278931 |
| 29 | Abnormality of complement system (HP:0005339) | 3.99555940 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93657422 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 3.89119676 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 3.89119676 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81396121 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80394185 |
| 35 | Pancreatic fibrosis (HP:0100732) | 3.79637157 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.78932584 |
| 37 | True hermaphroditism (HP:0010459) | 3.69909039 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.53607322 |
| 39 | Nephronophthisis (HP:0000090) | 3.42655895 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34872955 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.32248435 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32065954 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 3.30579920 |
| 44 | Type II lissencephaly (HP:0007260) | 3.26892004 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 3.23962005 |
| 46 | Steatorrhea (HP:0002570) | 3.22414975 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 3.21767554 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.18799980 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11866321 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 3.11658503 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 3.05272731 |
| 52 | Ketoacidosis (HP:0001993) | 3.02123182 |
| 53 | Myocardial infarction (HP:0001658) | 3.00013905 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.92818510 |
| 55 | Spontaneous abortion (HP:0005268) | 2.92135388 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.90530337 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.82962897 |
| 58 | Metabolic acidosis (HP:0001942) | 2.79393246 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.76830315 |
| 60 | Skin nodule (HP:0200036) | 2.74621049 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.71273815 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.70970770 |
| 63 | Medial flaring of the eyebrow (HP:0010747) | 2.69326298 |
| 64 | Vascular calcification (HP:0004934) | 2.69268959 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.63946436 |
| 66 | Hyperalaninemia (HP:0003348) | 2.63946436 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.63946436 |
| 68 | Polydipsia (HP:0001959) | 2.63504674 |
| 69 | Abnormal drinking behavior (HP:0030082) | 2.63504674 |
| 70 | Lethargy (HP:0001254) | 2.61223561 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60523485 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.60523485 |
| 73 | Tubular atrophy (HP:0000092) | 2.57373385 |
| 74 | Cystic liver disease (HP:0006706) | 2.56604589 |
| 75 | Mitral stenosis (HP:0001718) | 2.52335066 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50431668 |
| 77 | Hypoglycemic seizures (HP:0002173) | 2.48894538 |
| 78 | Pendular nystagmus (HP:0012043) | 2.46955506 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.46071663 |
| 80 | Spastic diplegia (HP:0001264) | 2.43645092 |
| 81 | Gout (HP:0001997) | 2.43621794 |
| 82 | Chronic hepatic failure (HP:0100626) | 2.42949628 |
| 83 | Hyperventilation (HP:0002883) | 2.42752868 |
| 84 | Stomach cancer (HP:0012126) | 2.41324664 |
| 85 | Cholelithiasis (HP:0001081) | 2.40852176 |
| 86 | Acanthocytosis (HP:0001927) | 2.40302173 |
| 87 | Neonatal onset (HP:0003623) | 2.37991419 |
| 88 | Large for gestational age (HP:0001520) | 2.37840240 |
| 89 | Cholecystitis (HP:0001082) | 2.37296249 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.37296249 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.37255142 |
| 92 | Irritability (HP:0000737) | 2.36394664 |
| 93 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.36168292 |
| 94 | Inability to walk (HP:0002540) | 2.34827796 |
| 95 | Cerebral edema (HP:0002181) | 2.34156517 |
| 96 | Glomerulonephritis (HP:0000099) | 2.33201558 |
| 97 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32097321 |
| 98 | Malnutrition (HP:0004395) | 2.31346173 |
| 99 | Hypothermia (HP:0002045) | 2.30528833 |
| 100 | Decreased central vision (HP:0007663) | 2.28888607 |
| 101 | Mitochondrial inheritance (HP:0001427) | 2.28633665 |
| 102 | Keratoconus (HP:0000563) | 2.28032248 |
| 103 | Increased corneal curvature (HP:0100692) | 2.28032248 |
| 104 | Acute necrotizing encephalopathy (HP:0006965) | 2.26187823 |
| 105 | Polyuria (HP:0000103) | 2.25597320 |
| 106 | 3-Methylglutaconic aciduria (HP:0003535) | 2.24242118 |
| 107 | Cerebellar dysplasia (HP:0007033) | 2.24068376 |
| 108 | Furrowed tongue (HP:0000221) | 2.23245711 |
| 109 | Amyloidosis (HP:0011034) | 2.20481325 |
| 110 | Stomatitis (HP:0010280) | 2.18641111 |
| 111 | Increased CSF lactate (HP:0002490) | 2.18637309 |
| 112 | Bile duct proliferation (HP:0001408) | 2.18611419 |
| 113 | Abnormal biliary tract physiology (HP:0012439) | 2.18611419 |
| 114 | Sclerocornea (HP:0000647) | 2.18463042 |
| 115 | Esophageal varix (HP:0002040) | 2.16589369 |
| 116 | Gingival bleeding (HP:0000225) | 2.15536087 |
| 117 | Thyroiditis (HP:0100646) | 2.15385127 |
| 118 | Progressive inability to walk (HP:0002505) | 2.14966043 |
| 119 | Enlarged kidneys (HP:0000105) | 2.14796301 |
| 120 | Menorrhagia (HP:0000132) | 2.13897755 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 2.13822123 |
| 122 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.13244422 |
| 123 | Absent/shortened dynein arms (HP:0200106) | 2.13244422 |
| 124 | Opisthotonus (HP:0002179) | 2.12096166 |
| 125 | Pancreatitis (HP:0001733) | 2.11633795 |
| 126 | Brushfield spots (HP:0001088) | 2.11461079 |
| 127 | Methylmalonic acidemia (HP:0002912) | 2.10197030 |
| 128 | Late onset (HP:0003584) | 2.09352271 |
| 129 | Gaze-evoked nystagmus (HP:0000640) | 2.08305531 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07495920 |
| 131 | Vomiting (HP:0002013) | 2.07355797 |
| 132 | Severe muscular hypotonia (HP:0006829) | 2.06631774 |
| 133 | Progressive macrocephaly (HP:0004481) | 2.05782773 |
| 134 | Lissencephaly (HP:0001339) | 2.05436027 |
| 135 | Thrombophlebitis (HP:0004418) | 2.04860387 |
| 136 | IgG deficiency (HP:0004315) | 2.03885861 |
| 137 | Optic disc pallor (HP:0000543) | 2.02107446 |
| 138 | Hemorrhage of the eye (HP:0011885) | 2.01325318 |
| 139 | Abnormality of the gallbladder (HP:0005264) | 2.00444695 |
| 140 | Constricted visual fields (HP:0001133) | 2.00330862 |
| 141 | Rickets (HP:0002748) | 1.99787920 |
| 142 | Gait imbalance (HP:0002141) | 1.99295592 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.98683353 |
| 144 | Acute encephalopathy (HP:0006846) | 1.98428313 |
| 145 | Hypoplasia of the pons (HP:0012110) | 1.98412228 |
| 146 | Anencephaly (HP:0002323) | 1.98271922 |
| 147 | Abnormality of the pons (HP:0007361) | 1.97176559 |
| 148 | Congenital hepatic fibrosis (HP:0002612) | 1.96738081 |
| 149 | Methylmalonic aciduria (HP:0012120) | 1.95954187 |
| 150 | Decreased circulating renin level (HP:0003351) | 1.94485824 |
| 151 | Male pseudohermaphroditism (HP:0000037) | 1.93808457 |
| 152 | Progressive cerebellar ataxia (HP:0002073) | 1.93571240 |
| 153 | Congenital primary aphakia (HP:0007707) | 1.92733531 |
| 154 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92681755 |
| 155 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91866913 |
| 156 | Poikilocytosis (HP:0004447) | 1.91830756 |
| 157 | Status epilepticus (HP:0002133) | 1.90651732 |
| 158 | Hepatocellular necrosis (HP:0001404) | 1.88246577 |
| 159 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88159034 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87953559 |
| 161 | Abnormality of proline metabolism (HP:0010907) | 1.87897720 |
| 162 | Hydroxyprolinuria (HP:0003080) | 1.87897720 |
| 163 | Abnormal cartilage morphology (HP:0002763) | 1.87612705 |
| 164 | Hypophosphatemic rickets (HP:0004912) | 1.87364978 |
| 165 | Renal cortical cysts (HP:0000803) | 1.87100984 |
| 166 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.87099989 |
| 167 | Clumsiness (HP:0002312) | 1.85809744 |
| 168 | Abnormality of iron homeostasis (HP:0011031) | 1.85749150 |
| 169 | Hepatic necrosis (HP:0002605) | 1.85692565 |
| 170 | Abnormal urine output (HP:0012590) | 1.84554516 |
| 171 | Febrile seizures (HP:0002373) | 1.84436065 |
| 172 | Alkalosis (HP:0001948) | 1.83617360 |
| 173 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82995879 |
| 174 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.82501099 |
| 175 | Abnormality of B cell number (HP:0010975) | 1.82200376 |
| 176 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80375524 |
| 177 | Elevated hepatic transaminases (HP:0002910) | 1.79680447 |
| 178 | Fair hair (HP:0002286) | 1.78040461 |
| 179 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77756820 |
| 180 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77756820 |
| 181 | Abnormality of vitamin metabolism (HP:0100508) | 1.76313330 |
| 182 | Lipid accumulation in hepatocytes (HP:0006561) | 1.75509551 |
| 183 | Hypoproteinemia (HP:0003075) | 1.75034524 |
| 184 | Intestinal atresia (HP:0011100) | 1.74515209 |
| 185 | Hypoplasia of the fovea (HP:0007750) | 1.73359701 |
| 186 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.73359701 |
| 187 | Hypoalbuminemia (HP:0003073) | 1.73113051 |
| 188 | Abnormal albumin level (HP:0012116) | 1.73113051 |
| 189 | Hypomagnesemia (HP:0002917) | 1.72665084 |
| 190 | Postaxial foot polydactyly (HP:0001830) | 1.72585975 |
| 191 | Asplenia (HP:0001746) | 1.71077079 |
| 192 | Broad-based gait (HP:0002136) | 1.69913920 |
| 193 | Hyperglycemia (HP:0003074) | 1.69436193 |
| 194 | Abnormality of renal excretion (HP:0011036) | 1.67903361 |
| 195 | Acute hepatic failure (HP:0006554) | 1.67890246 |
| 196 | Pachygyria (HP:0001302) | 1.67754971 |
| 197 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.67551799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.98736234 |
| 2 | SIK1 | 4.91033126 |
| 3 | ERN1 | 4.68669147 |
| 4 | FGFR4 | 4.60977392 |
| 5 | ADRBK2 | 3.63189686 |
| 6 | TAOK3 | 3.28988527 |
| 7 | MAP4K2 | 2.99613701 |
| 8 | TXK | 2.89700547 |
| 9 | INSRR | 2.85546431 |
| 10 | ERBB4 | 2.82363527 |
| 11 | ACVR1B | 2.69618771 |
| 12 | NUAK1 | 2.55172224 |
| 13 | TLK1 | 2.51591610 |
| 14 | ZAK | 2.47699408 |
| 15 | MAP2K4 | 2.47642915 |
| 16 | WNK4 | 2.44464602 |
| 17 | BMPR1B | 2.42377186 |
| 18 | WNK3 | 2.27485210 |
| 19 | MST1R | 1.90066202 |
| 20 | MAPK11 | 1.88501653 |
| 21 | PKN2 | 1.88452259 |
| 22 | FLT3 | 1.80708575 |
| 23 | LATS1 | 1.74527978 |
| 24 | PIK3CG | 1.73507652 |
| 25 | TYK2 | 1.63663187 |
| 26 | OXSR1 | 1.60932334 |
| 27 | MAPK13 | 1.49222910 |
| 28 | TNIK | 1.43983193 |
| 29 | TRIB3 | 1.43430808 |
| 30 | ABL2 | 1.43152177 |
| 31 | DAPK2 | 1.42883953 |
| 32 | STK39 | 1.41616674 |
| 33 | NEK9 | 1.32524389 |
| 34 | CASK | 1.31778917 |
| 35 | PTK6 | 1.29174203 |
| 36 | CAMKK2 | 1.27753182 |
| 37 | PINK1 | 1.24900202 |
| 38 | MAP3K4 | 1.23816039 |
| 39 | FGFR2 | 1.23205276 |
| 40 | KDR | 1.20937802 |
| 41 | MAP3K7 | 1.19449720 |
| 42 | GRK6 | 1.15722269 |
| 43 | JAK2 | 1.13890928 |
| 44 | STK38L | 1.13826765 |
| 45 | FRK | 1.12976136 |
| 46 | PRKAA2 | 1.12180857 |
| 47 | IKBKB | 1.10020198 |
| 48 | MAP3K14 | 1.09162211 |
| 49 | TBK1 | 1.06093741 |
| 50 | MAP2K3 | 1.03313025 |
| 51 | MST4 | 1.00520582 |
| 52 | ADRBK1 | 1.00167796 |
| 53 | ERBB2 | 0.98612730 |
| 54 | JAK1 | 0.97246226 |
| 55 | MAPK4 | 0.96786228 |
| 56 | MAP3K10 | 0.96145718 |
| 57 | MUSK | 0.95856762 |
| 58 | PAK3 | 0.94851976 |
| 59 | DYRK2 | 0.94253699 |
| 60 | PRKCE | 0.92889284 |
| 61 | PRKCZ | 0.91994023 |
| 62 | VRK1 | 0.91861660 |
| 63 | NLK | 0.91391111 |
| 64 | MAPK12 | 0.91224422 |
| 65 | MAPK15 | 0.90375935 |
| 66 | PNCK | 0.89263909 |
| 67 | STK16 | 0.89113100 |
| 68 | TGFBR1 | 0.84933342 |
| 69 | TIE1 | 0.84351328 |
| 70 | PHKG1 | 0.84271347 |
| 71 | PHKG2 | 0.84271347 |
| 72 | CSK | 0.82339537 |
| 73 | ITK | 0.80244861 |
| 74 | IRAK3 | 0.79420751 |
| 75 | MAP3K11 | 0.78393627 |
| 76 | PIK3CA | 0.78189287 |
| 77 | MAP2K6 | 0.77340091 |
| 78 | TEC | 0.76821357 |
| 79 | GRK7 | 0.75453119 |
| 80 | SYK | 0.74501152 |
| 81 | PRKACG | 0.74482066 |
| 82 | CDK6 | 0.73959347 |
| 83 | MAP2K7 | 0.73494503 |
| 84 | MAPK7 | 0.72454755 |
| 85 | PLK2 | 0.72187897 |
| 86 | MAPKAPK3 | 0.71565326 |
| 87 | ERBB3 | 0.69086914 |
| 88 | EPHA4 | 0.68982227 |
| 89 | PRKAA1 | 0.68888989 |
| 90 | DYRK1B | 0.68850353 |
| 91 | TGFBR2 | 0.67901231 |
| 92 | CAMK2G | 0.67834579 |
| 93 | MET | 0.67773995 |
| 94 | TAOK2 | 0.67594326 |
| 95 | TRIM28 | 0.66722832 |
| 96 | CAMK1D | 0.66708920 |
| 97 | EPHB1 | 0.66425076 |
| 98 | MAP3K3 | 0.66148175 |
| 99 | EPHA3 | 0.66030245 |
| 100 | MKNK2 | 0.64495648 |
| 101 | CHUK | 0.64314800 |
| 102 | SGK3 | 0.64069774 |
| 103 | GSK3A | 0.62787350 |
| 104 | CSF1R | 0.62421398 |
| 105 | GRK1 | 0.58858351 |
| 106 | RPS6KA5 | 0.57538327 |
| 107 | CAMK2A | 0.56751402 |
| 108 | IKBKE | 0.56682083 |
| 109 | CAMK1 | 0.56041661 |
| 110 | VRK2 | 0.54973359 |
| 111 | MAPKAPK5 | 0.54169887 |
| 112 | MAP2K2 | 0.53373913 |
| 113 | MAP4K1 | 0.53134094 |
| 114 | AKT3 | 0.52916095 |
| 115 | ICK | 0.52875359 |
| 116 | PTK2 | 0.51937981 |
| 117 | FGFR3 | 0.51511096 |
| 118 | MAP3K6 | 0.50805644 |
| 119 | SGK2 | 0.50601753 |
| 120 | TNK2 | 0.50494901 |
| 121 | SIK3 | 0.50388870 |
| 122 | PTK2B | 0.49624793 |
| 123 | LYN | 0.49108542 |
| 124 | MATK | 0.48578174 |
| 125 | LATS2 | 0.48349275 |
| 126 | PRKCQ | 0.48063303 |
| 127 | PRKACA | 0.47124582 |
| 128 | PDPK1 | 0.46535785 |
| 129 | CAMK4 | 0.45654575 |
| 130 | NTRK3 | 0.45057422 |
| 131 | CSNK1G1 | 0.44124606 |
| 132 | MAP3K5 | 0.43923685 |
| 133 | LCK | 0.43781709 |
| 134 | SIK2 | 0.43498008 |
| 135 | NTRK2 | 0.43449996 |
| 136 | PRKCG | 0.42713001 |
| 137 | CSNK1A1 | 0.42614888 |
| 138 | CDK4 | 0.40831554 |
| 139 | CDK19 | 0.40445883 |
| 140 | IGF1R | 0.39750120 |
| 141 | MAP3K13 | 0.38165904 |
| 142 | BCR | 0.38067554 |
| 143 | RIPK1 | 0.37716890 |
| 144 | PKN1 | 0.37116600 |
| 145 | STK11 | 0.36283670 |
| 146 | MARK1 | 0.35468687 |
| 147 | DYRK1A | 0.34910809 |
| 148 | CDK3 | 0.34197642 |
| 149 | EGFR | 0.33527462 |
| 150 | TRPM7 | 0.33367815 |
| 151 | STK3 | 0.32921800 |
| 152 | MAP2K1 | 0.32691931 |
| 153 | CSNK1A1L | 0.32173075 |
| 154 | PRKCI | 0.31746940 |
| 155 | MTOR | 0.30974739 |
| 156 | IRAK2 | 0.30402305 |
| 157 | SGK223 | 0.30213403 |
| 158 | SGK494 | 0.30213403 |
| 159 | RET | 0.27895703 |
| 160 | PDK1 | 0.27767639 |
| 161 | PRKCA | 0.25652224 |
| 162 | CSNK1G2 | 0.24413977 |
| 163 | IRAK1 | 0.23386221 |
| 164 | CSNK1G3 | 0.21061420 |
| 165 | KIT | 0.20847466 |
| 166 | ABL1 | 0.20571745 |
| 167 | MAPK3 | 0.18349546 |
| 168 | BLK | 0.18027631 |
| 169 | BMX | 0.17498723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.61324084 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40583146 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38599993 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33921321 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07611571 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77975402 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67652240 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65459193 |
| 9 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62301668 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54885642 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46025845 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.43676532 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40815347 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.40069475 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30582346 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16074594 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16063546 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.09978444 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02323942 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01469868 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99378455 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98998078 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96793032 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91961084 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91230213 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85212347 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84499121 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.81366450 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79833680 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.79192524 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78983060 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77067380 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74669851 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74386204 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73020753 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72415375 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71155624 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70267716 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63121606 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60898053 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.58721384 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55696399 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54861607 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54211850 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.53846511 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51958665 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49542389 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.49504530 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49447041 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 1.48820606 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48602546 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45111141 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44024305 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35990066 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34210233 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30013423 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29515160 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28309544 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26512611 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 1.25944504 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 1.25763653 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23534908 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21167352 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20034320 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 1.19722742 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18070395 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11442359 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10994520 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09243976 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07428395 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05065830 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04237895 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03947640 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02665569 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02649518 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 1.02584951 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 1.02440963 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01816496 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98779993 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97313413 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96467538 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95962170 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95349440 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94010674 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91185877 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90395523 |
| 87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88652556 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87999084 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.83424650 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83232987 |
| 91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81760136 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79984506 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.77985020 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.77393031 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75387088 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.73853919 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69902327 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69249928 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68025753 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68010477 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63799309 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62843608 |
| 103 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59393482 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.56701902 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.55533092 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55126183 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54611819 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53952964 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52428814 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49976877 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49391934 |
| 112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.47472440 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.47238531 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47061908 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45739472 |
| 116 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45737461 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44218533 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42333915 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.38863287 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38843024 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33634879 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29531213 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26673887 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26555824 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26502436 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23670071 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.20724439 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19120564 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16685247 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15125730 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08110584 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2457259 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | -0.2452372 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2430472 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2416043 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2412964 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2202087 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2171520 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2131745 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2059215 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | -0.1782146 |
| 142 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1673441 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1606567 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1508681 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1431359 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1375637 |
| 147 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1253038 |
| 148 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1216935 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0726971 |
| 150 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0594908 |
| 151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0578122 |
| 152 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0412364 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0014843 |

